Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC6A3 |
Upstream (Parents) |
---|
(<<) CA11 → SLC6A3 |
(<<) CACNG3 → SLC6A3 |
(<<) ICAM4 → SLC6A3 |
(<<) PADI2 → SLC6A3 |
(<<) TSGA14 → SLC6A3 |
(<<) ADAM21P1///ADAM21 → SLC6A3 |
(<<) DVL3 → SLC6A3 |
(<<) HIST1H3H → SLC6A3 |
Downstream (Children) |
---|
SLC6A3 → PSCA (>>) |
SLC6A3 → HR44 (>>) |
SLC6A3 → ATP6V0A4 (>>) |
SLC6A3 → MAGEC3 (>>) |
SLC6A3 → TSGA14 (>>) |